drugset / Trial / NCT00657553
Preemptive Strike With Bortezomib in Multiple Myeloma Patients
RandomizedSingle-groupOpen-labelTreatment
Summary
To evaluate whether using the drug bortezomib at the start of remission will prevent relapse for a longer period of time.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bortezomib | Small molecule | 1 mg/m2 | Intravenous |